KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Gross Margin (2016 - 2025)

Historic Gross Margin for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to 67.16%.

  • Globus Medical's Gross Margin rose 104000.0% to 67.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.34%, marking a year-over-year increase of 72000.0%. This contributed to the annual value of 58.9% for FY2024, which is 61500.0% down from last year.
  • Latest data reveals that Globus Medical reported Gross Margin of 67.16% as of Q3 2025, which was up 104000.0% from 66.62% recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Gross Margin registered a high of 75.8% during Q1 2021, and its lowest value of 56.77% during Q3 2024.
  • Moreover, its 5-year median value for Gross Margin was 73.78% (2023), whereas its average is 68.61%.
  • Its Gross Margin has fluctuated over the past 5 years, first plummeted by -173400bps in 2023, then soared by 104000bps in 2025.
  • Quarter analysis of 5 years shows Globus Medical's Gross Margin stood at 75.28% in 2021, then decreased by -1bps to 74.28% in 2022, then decreased by -23bps to 56.94% in 2023, then increased by 5bps to 59.92% in 2024, then increased by 12bps to 67.16% in 2025.
  • Its Gross Margin stands at 67.16% for Q3 2025, versus 66.62% for Q2 2025 and 67.33% for Q1 2025.